Company intelligence
Geistlich
Leading regeneration
About Geistlich
Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas
Verified activity
Signals from Geistlich
3 published signals
Products & Services
Geistlich Bio-Gide Forte combines the proven Geistlich Bio-Gide Technology with advanced handling and high tensile strength for demanding regenerative procedures.
Reported by Geistlich
Presence & Recognition
Geistlich is hosting a webinar titled GeistlichWebinartour on September 29, 2026, featuring Prof. Mariano Sanz and Dr. Ignacio Sanz-Sánchez discussing surgical protocols for peri-implantitis treatment.
Reported by Geistlich
Products & Services
Geistlich commemorated its 175-year anniversary with a commemorative book featuring historical photos and stories from its long company history.
Reported by Geistlich